Compliance to therapy with Dapoxetine in comparison to a conventional selective serotonin reuptake inhibitor (Citalopram) in 118 patients with premature ejaculation.
- Autori: Pavone, C; Abbadessa, D; Scaduto, G; Caruana, G; Gambino, G; Serretta, V; Scalici Gesolfo, C
- Anno di pubblicazione: 2013
- Tipologia: eedings
- OA Link: http://hdl.handle.net/10447/87983
Abstract
Premature Ejaculation (PE) is a sexual dysfunction that concern 20-30% of the male population. Dapoxetine is a new serotonine re-uptake inhibitor (SSRI)specific for PE treatment.Aim of the study is to assess compliance and effectiveness of the treatment with dapoxetine compared to the treatment with citalopram (a classic SSRI used to treat PE).